When patients develop brain metastasis from hepatocellular carcinoma, do the levels of VEGF-C and CCR7 in cerebrospinal fluid also change and become our molecular indicators to detect brain metastasis? This evidence concerns the gene CCR7 and hepatocellular carcinoma.